Insight
The October edition of editors’ picks from the 10 AACR journals
AACR/X

The October edition of editors’ picks from the 10 AACR journals

American Association for Cancer Research (AACR) shared a post on X:

“The October edition of editors’ picks from the 10 AACR journals features a head-to-head comparison of two CAR T therapies, a new type of blood test for colorectal cancer, and more. Learn more on the AACR Blog.”

1. “A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas”

Authors: Federico Stella, Annalisa Chiappella, Beatrice Casadei, Rosalba Miceli, Paolo Corradini et al.

2. “The History of Chromosomal Instability in Genome-Doubled Tumors”

Authors: Toby Baker, Siqi Lai, Andrew Lynch, Maxime Tarabichi, Peter Van Loo et al.

3. “Blood Magnesium Level and Risk of Hepatocellular Carcinoma in a Prospective Liver Cirrhosis Cohort”

Authors: Xinyuan Zhang, Longgang Zhao, Qi Dai, Tao Hou, Christopher Danford, Michelle Lai, Xuehong Zhang.

4. “Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells”

Authors: Vasyl Eisenberg, Shiran Hoogi, Erel Katzman, Ayal Hendel, Cyrille Cohen et al.

5. “Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia”

Authors: Lincoln Strickland, Wendao Liu, Usama Hussein, Jennifer Bailey-Lundberg et al.

6. “Multidimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer”

Authors: Yuepeng Cao, Nannan Wang, Xuxiaochen Wu, Jun Bao, Liu Yang et al.

7. “A Genomics-Driven Artificial Intelligence–Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms”

Authors: Fresia Pareja, Higinio Dopeso, Yi Kan Wang, Thomas Fuchs, Jorge Reis-Filho et al.

8. “First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial”

Authors: Tao Li, Ying Dong, Yongzhong Wei, Zhaoming Ye, Binghao Li et al.

9. “Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial”

Authors: Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Anna Pokorska-Bocci, Keith Flaherty et al.

10. “NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion”

Authors: Katelyn Noronha, Karlie Lucas, Sateja Paradkar, Juan Vasquez, Ranjit Bindra et al.

12. “FZ-AD005, a Novel DLL3-Targeted Antibody–Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models”

Authors: Qingsong Guo, Bei Gao, Ruiwen Song, Wei Lu, Tong Yang et al.

13. “Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation”

Authors: Anna Rutkowska, Christian Eberl, Thilo Werner, Marcus Bantscheff, Giovanna Bergamini et al.

More posts featuring AACR.

AACR AACR Journals American Association for Cancer Research Annalisa Chiappella Beatrice Casadei Rosalba Miceli cancer Federico Stella Longgang Zhao OncoDaily Oncology Paolo Corradini Peter Van Loo Tao Hou Xinyuan Zhang